Norges Bank’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-83,500
Closed -$865K 2040
2023
Q1
$865K Sell
83,500
-341,209
-80% -$3.53M ﹤0.01% 2015
2022
Q4
$5.02M Hold
424,709
﹤0.01% 1780
2022
Q3
$8.91M Buy
424,709
+75,926
+22% +$1.59M ﹤0.01% 1577
2022
Q2
$10.8M Sell
348,783
-82,638
-19% -$2.57M ﹤0.01% 1527
2022
Q1
$17.7M Buy
431,421
+5,033
+1% +$207K ﹤0.01% 1457
2021
Q4
$18.5M Buy
426,388
+7,000
+2% +$304K ﹤0.01% 1521
2021
Q3
$21M Buy
419,388
+329,150
+365% +$16.5M ﹤0.01% 1453
2021
Q2
$5.68M Sell
90,238
-195,078
-68% -$12.3M ﹤0.01% 1887
2021
Q1
$26.5M Sell
285,316
-239,182
-46% -$22.2M 0.01% 1359
2020
Q4
$47M Buy
524,498
+37,080
+8% +$3.32M 0.01% 1016
2020
Q3
$50.4M Buy
487,418
+1,208
+0.2% +$125K 0.01% 835
2020
Q2
$38.4M Sell
486,210
-70,405
-13% -$5.57M 0.01% 1015
2020
Q1
$32.2M Hold
556,615
0.01% 942
2019
Q4
$30M Hold
556,615
0.01% 1266
2019
Q3
$29.1M Hold
556,615
0.01% 1229
2019
Q2
$26.9M Sell
556,615
-209,099
-27% -$10.1M 0.01% 1303
2019
Q1
$38.7M Sell
765,714
-70,685
-8% -$3.57M 0.01% 1034
2018
Q4
$49.6M Hold
836,399
0.02% 749
2018
Q3
$55.1M Buy
836,399
+16,578
+2% +$1.09M 0.02% 788
2018
Q2
$41.4M Buy
819,821
+249,196
+44% +$12.6M 0.01% 982
2018
Q1
$30M Buy
570,625
+53,997
+10% +$2.84M 0.01% 1148
2017
Q4
$24M Buy
516,628
+72,953
+16% +$3.39M 0.01% 1353
2017
Q3
$17.9M Hold
443,675
0.01% 1514
2017
Q2
$15M Buy
443,675
+67,169
+18% +$2.28M 0.01% 1579
2017
Q1
$10.9M Hold
376,506
﹤0.01% 1701
2016
Q4
$12.4M Hold
376,506
0.01% 1595
2016
Q3
$11.3M Buy
376,506
+63,000
+20% +$1.9M 0.01% 1579
2016
Q2
$8.82M Buy
313,506
+133,106
+74% +$3.74M ﹤0.01% 1673
2016
Q1
$6.56M Buy
+180,400
New +$6.56M ﹤0.01% 1740